In addition, ATAD2 inhibition by miR-506 can improve lung adenocarcinoma's sensitivity to cisplatin-based hyperthermia by inhibiting the ATAD2-PI3K-AKT pathway 53. This evidence concerns the gene ATAD2 and lung adenocarcinoma.